These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 6486265)

  • 1. Duration of ECT-induced tachycardia as a measure of seizure length.
    Larson G; Swartz C; Abrams R
    Am J Psychiatry; 1984 Oct; 141(10):1269-71. PubMed ID: 6486265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of age and sex on electroconvulsive therapy using remifentanil as the sole anesthetic agent.
    Hossain A; Sullivan P
    J ECT; 2008 Sep; 24(3):232-5. PubMed ID: 18562948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring the duration of electroconvulsive therapy seizures: 'cuff' and EEG methods compared.
    Fink M; Johnson L
    Arch Gen Psychiatry; 1982 Oct; 39(10):1189-91. PubMed ID: 7125848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between seizure onset zone and ictal tachycardia: An intracranial EEG study.
    Stefanidou M; Carlson C; Friedman D
    Clin Neurophysiol; 2015 Dec; 126(12):2255-60. PubMed ID: 25817466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of esmolol pretreatment on EEG seizure morphology in RUL ECT.
    McCall WV; Zvara D; Brooker R; Arias L
    Convuls Ther; 1997 Sep; 13(3):175-80. PubMed ID: 9342133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Moderate hyperventilation prolongs electroencephalogram seizure duration of the first electroconvulsive therapy.
    Sawayama E; Takahashi M; Inoue A; Nakajima K; Kano A; Sawayama T; Okutomi T; Miyaoka H
    J ECT; 2008 Sep; 24(3):195-8. PubMed ID: 18772703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Latencies from intracranial seizure onset to ictal tachycardia: A comparison to surface EEG patterns and other clinical signs.
    Hirsch M; Altenmüller DM; Schulze-Bonhage A
    Epilepsia; 2015 Oct; 56(10):1639-47. PubMed ID: 26282577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The bispectral electroencephalogram during modified electroconvulsive therapy under propofol anesthesia: relation with seizure duration and awakening.
    Gombar S; Aggarwal D; Khanna AK; Gombar KK; Chavan BS
    J ECT; 2011 Jun; 27(2):114-8. PubMed ID: 20562643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ictal electroencephalographic characteristics during electroconvulsive therapy: a review of determination and clinical relevance.
    Mayur P
    J ECT; 2006 Sep; 22(3):213-7. PubMed ID: 16957539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interrater reliability of 2 definitions of seizure adequacy in electroconvulsive therapy.
    Semple DM; Gunn W; Ellahi R; Queirazza F
    J ECT; 2013 Mar; 29(1):21-4. PubMed ID: 23303415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationships between seizure duration and seizure threshold and stimulus dosage at electroconvulsive therapy: implications for electroconvulsive therapy practice.
    Chung KF
    Psychiatry Clin Neurosci; 2002 Oct; 56(5):521-6. PubMed ID: 12193241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The largest Lyapunov exponent of the EEG during ECT seizures as a measure of ECT seizure adequacy.
    Krystal AD; Zaidman C; Greenside HS; Weiner RD; Coffey CE
    Electroencephalogr Clin Neurophysiol; 1997 Dec; 103(6):599-606. PubMed ID: 9546486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of etomidate on seizure duration and electrical stimulus dose in seizure-resistant patients during electroconvulsive therapy.
    Khalid N; Atkins M; Kirov G
    J ECT; 2006 Sep; 22(3):184-8. PubMed ID: 16957534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparable seizure characteristics in magnetic seizure therapy and electroconvulsive therapy for major depression.
    Kayser S; Bewernick BH; Hurlemann R; Soehle M; Schlaepfer TE
    Eur Neuropsychopharmacol; 2013 Nov; 23(11):1541-50. PubMed ID: 23820052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Etomidate and seizure duration in electroconvulsive therapy: is there a dose-dependent relation?
    van Lammeren A; Dols A; van de Ven PM; Greuters S; Boer C; Loer SA; Stek ML
    J ECT; 2013 Jun; 29(2):101-5. PubMed ID: 23519220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intercorrelation of physiological seizure parameters and hormonal changes in electroconvulsive therapy.
    Thörnblom E; Gingnell M; Cunningham JL; Landén M; Bodén R
    Nord J Psychiatry; 2023 Apr; 77(3):312-318. PubMed ID: 35968653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measuring electroencephalographic seizure adequacy during electroconvulsive therapy: a comparison of 2 definitions.
    Rattehalli RD; Thirthalli J; Rawat V; Gangadhar BN; Adams CE
    J ECT; 2009 Dec; 25(4):243-5. PubMed ID: 19444140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seizure length in electroconvulsive therapy as a function of age, sex, and treatment number.
    Rasimas JJ; Stevens SR; Rasmussen KG
    J ECT; 2007 Mar; 23(1):14-6. PubMed ID: 17435566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Naloxone fails to prolong seizure length in ECT.
    Rasmussen KG; Pandurangi AK
    J ECT; 1999 Dec; 15(4):258-61. PubMed ID: 10614032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and feasibility of magnetic seizure therapy (MST) in major depression: randomized within-subject comparison with electroconvulsive therapy.
    Lisanby SH; Luber B; Schlaepfer TE; Sackeim HA
    Neuropsychopharmacology; 2003 Oct; 28(10):1852-65. PubMed ID: 12865903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.